A
1.06
0.06 (6.00%)
| Previous Close | 1.00 |
| Open | 1.01 |
| Volume | 107,382 |
| Avg. Volume (3M) | 195,724 |
| Market Cap | 22,450,412 |
| Price / Sales | 205.85 |
| Price / Book | 3.57 |
| 52 Weeks Range |
| Operating Margin (TTM) | -5,822.92% |
| Diluted EPS (TTM) | -3.19 |
| Quarterly Revenue Growth (YOY) | 75.60% |
| Total Debt/Equity (MRQ) | 149.87% |
| Current Ratio (MRQ) | 2.89 |
| Operating Cash Flow (TTM) | -29.93 M |
| Levered Free Cash Flow (TTM) | -28.82 M |
| Return on Assets (TTM) | -82.76% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Adagio Medical Holdings, Inc | - | - |
AIStockmoo Score
1.0
| Analyst Consensus | 2.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 2.0 |
| Average | 1.00 |
|
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| % Held by Insiders | 0.29% |
| % Held by Institutions | 85.46% |
| 52 Weeks Range | ||
| Median | 4.00 (277.36%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Lake Street | 02 Dec 2025 | 4.00 (277.36%) | Buy | 0.908 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 04 Feb 2026 | Announcement | New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia |
| 02 Feb 2026 | Announcement | Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 22 Dec 2025 | Announcement | Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness |
| 11 Dec 2025 | Announcement | Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors |
| 12 Nov 2025 | Announcement | Adagio Medical Reports Third Quarter 2025 Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |